Gates Foundation Gives $100 Million for Anti-HIV Gels
February 25, 2009
The global quest for a vaginal gel or similar product to fight HIV infection received a big boost this week from the Bill and Melinda Gates Foundation, which announced a $100 million donation to the Maryland-based International Partnership for Microbicides (IPM).
These donations follow good news recently reported by the US National Institutes of Health. NIH said a Phase II clinical trial of the microbicide candidate PRO2000, which is based on some of the same antiretrovirals used to treat HIV patients, had proved 30 percent more effective than other products in preventing HIV infection. Results of a Phase III trial of the gel involving 9,400 women in Africa are expected in August.
Agence France Presse
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.